Biotech ETF Sees Upside; Related Names Higher (GILD) (CELG) (BIIB) (AMGN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Regeneron Pharmaceuticals (REGN) Higher as Sanofi Raises Stake in 20.5%
July 1, 2014 10:30 AM EDTRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is 5.5% higher today after Sanofi (NYSE: SNY) disclosed in an amended 13D filing that it raised its stake to 20.5%, or 20,258,841 shares. The firm bought an aggregate of 240,751 shares of Common Stock in recent market transactions.
Item 4. Purpose of Transaction.
Item 4 of the Schedule 13D is supplemented as follows:
The Reporting Person has determined to purchase, directly or through its subsidiaries, additional shares of Common Stock to increase its beneficial ownership to... More
